Paclitaxel Pharmacokinetics And Response To Chemotherapy

Paclitaxel Pharmacokinetics And Response To Chemotherapy In Patients With Advanced Cancer Treated With A Weekly Regimen This studied followed others in observing that paclitaxel pharmacokinetics [...]

Population Pharmacokinetics And Pharmacodynamics Of Paclitaxel And Carboplatin

Population Pharmacokinetics And Pharmacodynamics Of Paclitaxel And Carboplatin In Ovarian Cancer Patients: A Study By The European Organization For Research And Treatment Of Cancer-Pharmacology [...]

Paclitaxel Combined With Carboplatin In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Open-Label, Randomized Study Of Individualized, Pharmacokinetically (PK)-Guided Dosing Of Paclitaxel Combined With Carboplatin In Advanced Non-Small Cell Lung Cancer (NSCLC) Patients. This study [...]

Personalized Dosing via Pharmacokinetic Monitoring of 5-FU

Personalized Dosing via Pharmacokinetic Monitoring of 5-Fluorouracil Might Reduce Toxicity in Early- or Late-Stage Colorectal Cancer Patients Treated With Infusional 5-Fluorouracil-Based [...]

Modeling the 5-fluorouracil area under the curve versus dose relationship

Modeling the 5-fluorouracil area under the curve versus dose relationship to develop a pharmacokinetic dosing algorithm for colorectal cancer patients receiving FOLFOX6. Kaldate RR, Haregewoin A, [...]

Individual Fluorouracil Dose Adjustment

Individual Fluorouracil Dose Adjustment Based on Pharmacokinetic Follow-Up Compared With Conventional Dosage: Results of a Multicenter Randomized Trial of Patients With Metastatic Colorectal [...]

Prospective, multi-center study of 5-FU

Prospective, multi-center study of 5-fluorouracil (5-FU) therapeutic drug management (TDM) in metastatic colorectal cancer (mCRC) patients treated in routine clinical practice.Wilhelm M, Mueller [...]

Therapeutic drug monitoring of 5-fluorouracil

Therapeutic drug monitoring of 5-fluorouracil.   Lee JJ, Beumer JH, Chu E. Cancer Chemother Pharmacol. 2016 78(3):447-464. Review. This very recent and through review concluded: “Dose adjustment [...]

Trough Imatinib Plasma Levels

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia Picard S, Titier K, Etienne G, et al. Blood. [...]

Imatinib Pharmacokinetics

Imatinib pharmacokinetics and its correlation with response plasma exposure of imatinib and its correlation with clinical response in the tyrosine kinase inhibitor optimization and selectivity [...]

page 1 of 2